Company Data
VistaGen Therapeutics Inc.
Ticker
VTGN
Current Price
$4.89 -7.82%
Market Cap
$132.2M
Price Target
Refer to Report
Volume
321.8K
52wk Range
$1.62 - $24.71
Overview
VistaGen Therapeutics Inc is a biotechnology firm. The company is in its clinical stage and engaged in developing and commercializing product candidates for patients with diseases and disorders involving the central nervous system. Its lead product candidate, AV-101, is an orally available prodrug candidate in Phase II development, initially for the adjunctive treatment of a major depressive disorder in patients with an inadequate response to standard antidepressants.